MW DMK Pharma initiated with buy rating, $1.50 target price at Maxim Group
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
December 07, 2023 07:25 ET (12:25 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.